South Shore Capital Advisors’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-3,589
Closed -$259K 103
2022
Q1
$259K Buy
3,589
+959
+36% +$69.1K 0.42% 79
2021
Q4
$241K Buy
+2,630
New +$314K 0.39% 84
2021
Q2
Sell
-3,763
Closed -$684K 130
2021
Q1
$684K Hold
3,763
0.68% 33
2020
Q4
$752K Buy
+3,763
New +$765K 0.74% 35

Other funds holding TDOC

South Shore Capital Advisors's TDOC Position: Q2 2022 in Review

South Shore Capital Advisors sold out of Teladoc Health (TDOC) in Q2 2022, closing a stake of 3,589 shares — an estimated $259K sold.

South Shore Capital Advisors first reported a position in TDOC in Q4 2020 and held it in 4 quarters. The position peaked at $752K in Q4 2020. 550 funds tracked by Wall St. Rank hold TDOC as of Q2 2022.

  • South Shore Capital Advisors reported no remaining Teladoc Health position as of Q2 2022 after selling out during the quarter.
  • South Shore Capital Advisors sold 3,589 Teladoc Health shares in Q2 2022, an estimated $259K.
  • South Shore Capital Advisors first reported a position in Teladoc Health in Q4 2020 and held it in 4 quarters.
  • South Shore Capital Advisors's Teladoc Health position peaked at $752K in Q4 2020.
  • 550 funds tracked by Wall St. Rank held Teladoc Health as of Q2 2022.

Based on South Shore Capital Advisors's 13F filing for Q2 2022, filed 18 Jul 2022.